Concepedia

Author

Maria Gebre‐Medhin

Lund UniversityORCID

Also Known As

Gebre-Medhin, Maria, M. Gebre-Medhin, Maria Gebre-Medhin, Maria Gebre‐Medhin

36

Publications

526

Citations

10

H-Index

30

Concepts

All Affiliations

Lund UniversitySkåne University HospitalUniversity of GothenburgUmeå UniversitySahlgrenska University Hospital
MG

About

Maria Gebre‐Medhin is an author at Lund University specializing in medicine, cell biology, and endocrinology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

213

2

Health Sciences

2

2

117

3

Cell Biology

2

2

189

4

Endocrinology

2

2

189

5

Metabolism

1

1

93

Maria Gebre‐Medhin

×

9

Publications

469

Citations

9

H-Index

YearCitations

ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer

Maria Gebre‐Medhin, Eva Brun, Per Engström,

Journal of Clinical Oncology

2020

158

Growth Hormone Receptor Is Expressed in Human Breast Cancer

Maria Gebre‐Medhin, Lars‐Gunnar Kindblom, Håkan Wennbo,

American Journal Of Pathology

2001

96

Prolactin (PRL) Receptor Gene Expression in Mouse Adipose Tissue: Increases during Lactation and in PRL-Transgenic Mice<sup>1</sup>

Charlotte Ling, Gunnel Hellgren, Maria Gebre‐Medhin,

Endocrinology

2000

93

Dose-volume analysis of radiation-induced trismus in head and neck cancer patients

Maria Gebre‐Medhin, Mahnaz Haghanegi, Lotta Robért,

Acta Oncologica

2016

38

Haematological toxicity in adult patients receiving craniospinal irradiation – Indication of a dose-bath effect

Kristoffer Petersson, Maria Gebre‐Medhin, Crister Ceberg,

Radiotherapy and Oncology

2014

24

Circulating tumour HPV16 DNA quantification – A prognostic tool for progression-free survival in patients with HPV-related oropharyngeal carcinoma receiving curative chemoradiotherapy

Gabriel Adrian, Ola Forslund, Louise Pedersen,

Radiotherapy and Oncology

2023

24

Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy

Gabriel Adrian, Henrik Carlsson, Elisabeth Kjellén,

Radiation Oncology

2022

15

Altered fractionation diminishes importance of tumor volume in oropharyngeal cancer: Subgroup analysis of ARTSCAN‐trial

Gabriel Adrian, Maria Gebre‐Medhin, Elisabeth Kjellén,

Head & Neck

2020

11

A national study of health‐related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma

Malin Berg, Ali Adnan, Anders Högmo,

Head & Neck

2021

10

Page 1